GENE ONLINE|News &
Opinion
Blog

JPM
JPM 2024: Generative AI Reshapes Medical Paradigms, Transforming the Past
2024-01-15
JPM 2024: AZ, Ginkgo and Moderna Provides Business Updates, Illustrating Optimistic Prospects
2024-01-11
JPM 2024: Pfizer’s Strategic Moves in the Obesity Drug Market and BioNTech’s Oncology Pipeline Expansion
2024-01-10
JPM 2024: GSK Buys Aiolos Bio for $1.4 Billion, Cytokinetics Acquisition Sparks Three-way Contest
2024-01-10
JPM 2024: Biotech Companies Mapping Out Their Future, and a New Round of M&A Spree Begins
2024-01-09
Biotech Showcase 2023: Digital Medicine Innovation: Its Time is Now
2023-02-01
JPM23: More Deals as JP Morgan Healthcare Conference 2023 Enters the Third Day
2023-01-12
JPM23: More Deals Defining JP Morgan Healthcare Conference 2023 Day Two
2023-01-11
JPM23: Development and Strategic Updates from JP Morgan Healthcare Conference 2023 Day Two
2023-01-10
JPM23: Partnerships Take off From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
JPM23: Acquisition Announcements From JP Morgan Healthcare Conference 2023 Day One
2023-01-10
JPM22 Highlights: Innovative Partnerships to Reimagine Personalized Care
2022-01-11
JPM22 Highlights: Cell and Gene Therapies Rise Up
2022-01-11
JPM Healthcare Conference: Shape, Korro, and Ionis Present Advances in RNA Therapeutics
2021-01-18
Key Takeaways from the JPM Healthcare Conference: Gilead, Regeneron Lay Oncology Plans, Merck Looks Beyond Keytruda
2021-01-17
1 2
LATEST
Cortisol: New Discoveries on its Impact Across Health, Culture, and Evolution
2024-02-26
Why NVIDIA’s CEO Huang Said AI Fostering Life Science:Highlighting GPU’s Applications in Biotech
2024-02-23
Revolutionary AI-Powered Respiratory Monitor Maker Gets Financial Boost with Latest Funding
2024-02-21
Researchers Predict Drug Interactions with Machine Learning to Enhance Patient Safety
2024-02-21
USC-Led Study Reveals Benefits of Fasting-Mimicking Diet in Reducing Disease Risk and Slowing Aging
2024-02-21
Astonishing brain tumour research wins the BIAL Award in Biomedicine 2023 worth 300,000 Euro
2024-02-21
Targeted Cancer Therapy Breakthrough: Degrader-Antibody Conjugates (DACs) Advance to Clinical Trials
2024-02-19
EVENT
Scroll to Top